Moderated small-group networking table at the Swiss Biotech Day

ProgramModerated networking tables

Moderated networking tables

Thirty minutes, one topic, one table.

When
Both conference days, 30-minute slots between 14:30 and 17:40
Where
Rooms Rio and Mexico, level 2
Format
Open discussion for up to twelve participants with one moderator
Who hosts
Companies and service providers with a topic and a moderator
Access
Included in the conference pass; seats on a first-come basis

About the format

Moderated networking tables are small-group conversations on a focused question, hosted by an expert moderator. They run in half-hour slots throughout both afternoons and are the most direct way to talk shop with peers.

Each table is branded by its host and built around one question the host wants to discuss with the room: how AI is accelerating drug development, what surprised you most when scaling from research to clinical trials, whether Switzerland can lead the advanced therapies revolution. The moderator opens, the table talks.

Hosts submit the topic, a short summary and the moderator ahead of the event. Table, topic and host appear in the program, on the conference website and in the printed conference guide, so participants can plan which tables to join.

A moderated networking table at the Swiss Biotech Day.

Why take part

What moderated networking tables offer

  1. Depth over reach

    A dozen people around one table produce conversations a stage session cannot.

  2. Your topic, your moderator

    The host frames the question and leads the discussion.

  3. In the program

    Every table is listed with time, room and host in the program and the conference guide.

Last edition

Moderated networking tables at the Swiss Biotech Day 2026

See all 2026 networking tables
  • Monday, 14:30

    Challenges and solutions in discovery, generation and characterization of multispecifics

    Adimab

  • Monday, 15:10

    Scaling from early research to clinical trials: what surprised you most?

    Clinigen

  • Monday, 15:50

    The right raw material at the right time

    IMPAG

  • Monday, 17:10

    From molecule to companion: building digital patient support in a regulated world

    Sciensus

  • Tuesday, 12:10

    From science to commercial: can Switzerland lead the advanced therapies revolution?

    Siegfried DINAMIQS

  • Tuesday, 12:50

    How AI is accelerating drug development from discovery to clinical

    Clinilabs

Have a question the industry should discuss?

Tell us the topic and we will find a slot on one of the two afternoons.